Blood screening is a medical process that detects markers of infection in order to prevent the release of infected blood and blood components for clinical use. This technology is widely used in various fields of diagnostics of diseases such as HIV, cancer, and infectious diseases.
|Study Period||Historical Data: 2015-19|
|Base Year: 2019|
|Forecast Period: 2020-25|
|Regions Covered||North America|
|Middle East & Africa|
|Key Companies Covered||
Global Blood Screening Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Blood Screening market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Blood Screening Market Analysis, 2020”, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F on an account of a boost in the geriatric population and surging number of trauma cases. In addition, growing technological advancement in blood screening, burgeoning government healthcare expenditure in infrastructural development of hospitals in the emerging economies such as India and China, and proliferating demand for blood screening tests due to rising blood donations by the people are key factors which are projected to lead to a considerable impact toward the growth of Global Blood Screening market in the forecast years.
Blood Bank Dominated the Global Screening Market
Based on end user, blood banks dominated the market and is projected to continue its dominance by 2025 owing to rising awareness and participation of the public in blood donation. Besides this, increasing awareness regarding the safety of blood, rising government funding to charitable trusts along with a significant rise in the organ transplantation surgeries and road accidents across the globe is anticipated to strongly contribute toward the growth of the Blood Screening market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Blood Screening Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Blood Screening market include Grifols, Abbott, Roche, Bio-Rad, Biomerieux, Thermo Fisher, Diasorin, Perkinelmer etc.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation and Statistics:
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Blood Screening Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Blood Screening Market during 2020-25?
A. The growth rate of Global Blood Screening Market during 2020-25 is forecast to be grow at a CAGR of 8.5 %.
Q. Who are the key competitors or players operating in Global Blood Screening Market?
A. Grifols, Abbott, Roche, Bio-Rad, Biomerieux, Thermo Fisher, Diasorin, Perkinelmer etc., are few of the leading players in the Global Blood Screening Market.
Q. Which end-user segment would emerge as an opportunity area for players in Global Blood Screening Market?
A. Blood Bank is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Blood Screening Market?
A. North America grabbed a majority market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Blood Screening Market.